IMPATH to Report First Quarter 2001 Results April 25, 2001 - After Market Close

Apr 18, 2001, 01:00 ET from IMPATH Inc.

    NEW YORK, April 18 /PRNewswire/ -- IMPATH Inc. (Nasdaq:   IMPH) today
 announced that it plans to release its earnings for the first quarter ended
 March 31, 2001 on Wednesday, April 25, 2001, after market.   The Company will
 hold a live, webcast conference call at 8:45AM (EST) on Thursday, April 26,
 2001 which can be accessed from the Company's website (http://www.impath.com)
 and will thereafter be archived on the site for a period of time.  The call
 will be hosted by Dr. Anu Saad, Chairman and Chief Executive Officer, Richard
 Adelson, President and Chief Operating Officer and David Cammarata, Chief
 Financial Officer.
     IMPATH Inc. is in the business of improving outcomes for cancer patients.
 The Company is the leading source of cancer information and analyses with a
 database of about 700,000 analyzed cases to date.  IMPATH uses sophisticated
 technologies to provide patient-specific cancer diagnostic and prognostic
 information to pathologists, oncologists and transplant centers. IMPATH
 currently serves more than 7,850 physicians specializing in the treatment of
 cancer patients, in over 1,975 hospitals and 446 oncology practices. Utilizing
 its comprehensive resources, IMPATH Predictive Oncology serves genomics,
 biotechnology and pharmaceutical companies involved in developing new
 therapeutics targeted to specific, biological characteristics of cancer.
 
 

SOURCE IMPATH Inc.
    NEW YORK, April 18 /PRNewswire/ -- IMPATH Inc. (Nasdaq:   IMPH) today
 announced that it plans to release its earnings for the first quarter ended
 March 31, 2001 on Wednesday, April 25, 2001, after market.   The Company will
 hold a live, webcast conference call at 8:45AM (EST) on Thursday, April 26,
 2001 which can be accessed from the Company's website (http://www.impath.com)
 and will thereafter be archived on the site for a period of time.  The call
 will be hosted by Dr. Anu Saad, Chairman and Chief Executive Officer, Richard
 Adelson, President and Chief Operating Officer and David Cammarata, Chief
 Financial Officer.
     IMPATH Inc. is in the business of improving outcomes for cancer patients.
 The Company is the leading source of cancer information and analyses with a
 database of about 700,000 analyzed cases to date.  IMPATH uses sophisticated
 technologies to provide patient-specific cancer diagnostic and prognostic
 information to pathologists, oncologists and transplant centers. IMPATH
 currently serves more than 7,850 physicians specializing in the treatment of
 cancer patients, in over 1,975 hospitals and 446 oncology practices. Utilizing
 its comprehensive resources, IMPATH Predictive Oncology serves genomics,
 biotechnology and pharmaceutical companies involved in developing new
 therapeutics targeted to specific, biological characteristics of cancer.
 
 SOURCE  IMPATH Inc.